Pharmicell Co., Ltd.
005690 · KOSPI · Healthcare · ₩564.0B (approx. $423.0M)· Nat'l Pension stake 1.39% (2024-12-31)
₩9,400-4.1%vs prev closeclose of 2026-10-30 · not real-time
Valuation summary
Looks expensive
Pharmicell Co., Ltd., a biopharmaceutical company, develops and sells autologous drugs in South Korea and internationally. The company operates in Biopharmaceutical Business and Biochemical Business divisions.· Source: company profile (yfinance/Yahoo Finance)
Valuation summary30/100Downside rigidity21/100Upside potential34/100
vs. fair value1 analysts
+177%Undervalued
Price ₩9,400Fair value ₩26,000
vs. analyst consensus target. The target is an opinion, not a prediction or buy signal.
Score summary
Some axes lack data (–)
A summary of valuation factors — not a buy recommendation. You decide.
Data as of: 2026-10-30 · end-of-day, not real-timeData as of — price/valuation/technicals: the close date above · NPS stake: US=quarterly SEC 13F, Korea=annual · short interest: exchange's latest settlement · fundamentals: latest filing
Peers
| Company | PER | PBR | ROE | Div | Score |
|---|---|---|---|---|---|
| 파미셀 | 12.0 | 3.9 | -29% | 0.5% | 30 |
| 온코닉테라퓨틱스 | 22.1 | 6.3 | 34% | 0.0% | 46 |
| 동아제약 | 6.8 | 0.5 | 7% | 2.0% | 59 |
| 프로티나 | – | 25.8 | – | 0.0% | 33 |
| JW중외제약 | 5.6 | 1.3 | 28% | 2.8% | 68 |
| 보령 | 5.9 | 0.8 | 14% | 1.9% | 46 |
Same sector, nearest by market cap · – = no data (value traps excluded)
Price chart
View on Naver Finance →· Chart: Naver Finance
The chart (long-term trend, Ichimoku cloud) is for observation only — not a buy or sell signal.
Structure analysis · observation only
Shows only where the current price sits within the channel structure (based on past swings).
Position: 0.5~1.0 zone · Downtrend channelStructure as of 2026-10-30
Channel levels (price by multiple)
- Baseline (0)₩13,400
- ×0.5₩10,107
- Current price₩9,400
- ×1₩6,814
- ×1.5₩3,521
- ×2₩227
Unfilled gaps
- Gap downabove price₩11,200–₩11,310 · Gap width 0.98% · 2026-10-15
- Gap downabove price₩11,900–₩12,100 · Gap width 1.7% · 2026-10-13
- Gap upbelow priceBeyond chart₩6,054–₩6,144 · Gap width 1.5% · 2024-12-11
The channel, levels and gaps are observational geometry showing where the current price sits within past swing structure. They are not a rebound/bottom probability, a price target, or a buy/sell signal — plain chart patterns carry no reliable predictive edge (our backtest conclusion).
A highlight of the key metrics detailed below.
Undervalued vs sector 32/100 within Healthcare — higher means lower multiples (PER·PB·EV/EBITDA·PSR) than sector peers. Growth sectors carry higher multiples, so this is a same-sector relative view, not absolute cheapness (observational).
Why it looks cheap
- –
Why it might be risky
- P/B (Price/Book)3.9
Strategy ranks
Top-tier in 0 of 4 evaluated strategies
Ranks within the Korea market — tap to open that ranking (ranks are per market).
Valuation
- P/E (Price/Earnings)
- 12.0
- Forward P/E
- 7.4
- P/B (Price/Book)
- 3.9
- PEG
- –
- P/S (Price/Sales)
- 23.6
- Dividend Yield
- 0.5%
- FCF Yield
- –
- EV/EBITDA
- –
- EV/Sales
- 17.8
- Net Debt / EBITDA
- –
- P/CF (Price/Cash Flow)
- –
Quality & growth
- ROE (Return on Equity)
- -29.3%
- ROA (Return on Assets)
- -5.0%
- Rule of 40
- –
- Earnings Growth
- –
Past returns
1M
-22.7%
3M
+4.7%
6M
-48.6%
1Y
-30.0%
3Y
+19.5%
5Y
-42.5%
Past returns — they do not guarantee future results.
Enterprise value
Market cap
₩564.0B
Enterprise value (EV)
₩426.4B
Net debt
₩2.3B
vs market cap
75.6%
EV as reported by our data provider (Yahoo Finance) · net debt is our own calc (total debt − cash) · definitions differ, so EV need not equal market cap + net debt (minority interest, preferred stock)
More indicators
Sortino
-0.05
Downside vol
51.02%
Max drawdown (3y)
-56.74%
Deep historical drawdown
Volatility (annual.)
77.83%
Large price swings
RSI(14) daily
34.40
RSI(14) weekly
37.20
RSI(14) monthly
44.40
vs 200d MA
-31.73%
Below 200-day avg
Trend slope (annualized)
49.24%
Recent uptrend
FCF margin
-24.19%
Beta
0.61
Moves less than market
Payout ratio
6.45%
Sustainable
Price/Graham
1.44
Around fair value
Golden cross
✕ not aligned
Color: green = healthy, red = caution (absolute thresholds, value/quality metrics only). Downside vol & Sortino are annualized. Max drawdown = largest drop from a 3-year peak; volatility = 1-year annualized. Price/Graham < 1 = below Graham fair value (profitable, positive-equity names only). RSI < 30 = oversold. For reference only.
Long-term trend (Ichimoku)
A Japanese trend tool. Price above the 'cloud' is supportive; below is weak. A strong uptrend doesn't mean it's cheap — stocks that have run up are usually more expensive.
D
Below the cloud (weak)
W
Below the cloud (weak)
M
Inside the cloud (neutral)